Driving reinvestment in R&D for antibiotics and advocating their responsible use

Associate Partners

International institutions:

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Austria

World Bank

The Global Health Investment Fund (GHIF)

Swedish Ministry of Health

European Centre of Disease Prevention and Control (ECDC)

European Medicines Agency (EMA)

Center for Disease Dynamics, Economics & Policy (CDDEP)

Clinical societies:

European Society of Clinical Microbiology and Infectious Diseases (ESCMID), International Society for Chemotherapy (ISC), International Society of Infectious Diseases (ISID)

Alliance for the Prudent Use of Antibiotics (APUA)


The Boston University School of Law (Kevin Outersson)

Harvard School of Public Health (Rifat Atun)

University of South Australia (Allan Evans)